Clinical Trial Update: High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating high-dose chemotherapy with an allogeneic hematopoietic cell transplant for Non-Hodgkin lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: Stanford University | Conditions: Lymphoma, Non-Hodgkin, Blood and Marrow Transplant (BMT) | Phase 2 | Status: COMPLETED